Investor
The company's diagnostics platform helps predict how patients will respond to immunotherapy.
The company will use the funds to expand its commercial efforts and seek additional clinical validation of its tech-enabled offering.
The company will use the funds to grow its autism therapy practice, continue AI and LLM research, and develop clinical algorithms.
The VC firm's business venture, HATCo, announced it signed a letter of intent to purchase the nonprofit healthcare system and shift its focus to value-based care.
Holly Maloney, managing director at General Catalyst, discusses where AI is making waves in healthcare and how digital health funding will progress in 2024.
AI-powered dental practice technology company Peerlogic and AI-enabled clinical trial design company QuantHealth also scored investments.
The funding marks the completion of the company's merger with Amelia Virtual Care, and the investment will be used to support the combined companies' growth.
The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
The funds come two years after the company scored a $1.15 billion investment.